Lyme borreliosis is caused by multiple species of the spirochete bacteria Borrelia burgdorferi sensu lato. The spirochetes are transmitted by ticks to vertebrate hosts, including small-and medium-sized mammals, birds, reptiles, and humans. Strain-tostrain variation in host-specific infectivity has been documented, but the molecular basis that drives this differentiation is still unclear. Spirochetes possess the ability to evade host immune responses and colonize host tissues to establish infection in vertebrate hosts. In turn, hosts have developed distinct levels of immune responses when invaded by different species/strains of Lyme borreliae. Similarly, the ability of Lyme borreliae to colonize host tissues varies among different spirochete species/strains. One potential mechanism that drives this strain-to-strain variation of immune evasion and colonization is the polymorphic outer surface proteins produced by Lyme borreliae. In this review, we summarize research on strain-to-strain variation in host competence and discuss the evidence that supports the role of spirochete-produced protein polymorphisms in driving this variation in host specialization. Such information will provide greater insights into the adaptive mechanisms driving host and Lyme borreliae association, which will lead to the development of interventions to block pathogen spread and eventually reduce Lyme borreliosis health burden.
ability of Lyme borreliae to colonize host tissues varies among different spirochete species/strains. One potential mechanism that drives this strain-to-strain variation of immune evasion and colonization is the polymorphic outer surface proteins produced by Lyme borreliae. In this review, we summarize research on strain-to-strain variation in host competence and discuss the evidence that supports the role of spirochete-produced protein polymorphisms in driving this variation in host specialization. Such information will provide greater insights into the adaptive mechanisms driving host and Lyme borreliae association, which will lead to the development of interventions to block pathogen spread and eventually reduce Lyme borreliosis health burden.
Variability in host species association with Lyme borreliae
Lyme borreliosis is the most common vector-borne disease in the United States and Europe (Steere et al., 2016) . The disease is caused by the spirochetal bacteria Borrelia burgdorferi sensu lato (hereafter B. burgdorferi sl), which is vectored by Ixodes spp. ticks (Radolf et al., 2012) . Following a tick bite, the spirochetes can hematogenously disseminate from the tick bite site in the skin to distal tissues and organs within a host (Brisson et al., 2012) . In humans, the spirochete colonization of distal tissues leads to multiple pathologies, including arthritis, carditis and neuroborreliosis (Rosa et al., 2005) . In nature, ticks can acquire and transmit Lyme borreliae between multiple vertebrate reservoir hosts, including avian, reptile and mammalian hosts . The ability of B. burgdorferi to survive in ticks, be transmitted to, and systemically infect hosts is essential for the maintenance of this spirochete in the enzootic cycle.
Borrelia burgdorferi sl is comprised of more than 15 genospecies (subspecific designation of species based on genotypes), each comprising multiple strains (Mead, 2015; Steere et al., 2016) . Interestingly, an association between different classes of vertebrate hosts and some B. burgdorferi sl genospecies or strains has been observed (Table 1) . For example, B. afzelii, B. bavariensis, B. bissettii, B. californiensis, B. carolinensis, B. japonica, B. kurtenbachii, B. mayonii, B. spielmanii and B. yangtzensis have been found in rodents such as mice (field mice: Apodemus flavicollis and A. sylvaticus; wood/harvest mice: Micromys minutus) and voles (Clethrionomys glareolus, Microtus arvalis) (Kurtenbach et al., 1998a; Hanincova et al., 2003a; Richter et al., 2004b) , while B. garinii, B. valaisiana and B. turdi have typically been isolated from avian hosts such as the ringnecked pheasant (Phasianus colchicus), the Atlantic puffin (Fratercula arctica), the common blackbird (Turdus merula) and numerous other passerine species (Humair et al., 1998; Kurtenbach et al., 1998a; Gylfe et al., 1999; Hanincova et al., 2003b; Comstedt et al., 2006) . Borrelia lusitaniae was identified mainly in reptiles such as lizards (Richter and Matuschka, 2006; Amore et al., 2007) . The host-specific infection of these spirochetes indicates that these species are specialists in the enzootic cycle. Unlike the specialists, B. burgdoferi sensu stricto (hereafter B. burgdorferi) has been isolated from multiple classes of vertebrate animals (e.g. mammalian and avian hosts) and thus could be considered a generalist species (Lane and Loye, 1989; Levin et al., 1996; Kurtenbach et al., 2006; Swanson and Norris, 2007) . However, previous observations propose that some genotypes of B. burgdorferi are more prevalent in mammalian hosts such as small rodents whereas others are more widespread in avian hosts (Wang et al., 2002; Brisson and Dykhuizen, 2004; Brisson and Dykhuizen, 2006; Hanincova et al., 2006; Brinkerhoff et al., 2010; Vuong et al., 2014; Mechai et al., 2016) . These findings raise the possibility of interstrain variation of spirochete-host associations.
In support of this association, when different vertebrate hosts are infected by Lyme borreliae via ticks or needles, some spirochete species/strains preferentially infect small rodents (Matuschka and Spielman, 1992; Hu et al., 2001; Wang et al., 2002; Derdakova et al., 2004; Richter et al., 2004a; Hanincova et al., 2008; Craig-Mylius et al., 2009; Tonetti et al., 2015; Rynkiewicz et al., 2017) , while others more efficiently colonize avian hosts (e.g. pheasant, Coturnix quail and American robins) (Isogai et al., 1994; Kurtenbach et al., 2002b; Ginsberg et al., 2005) . Additionally, upon infection, Lyme borreliae species/strains differ in their ability to survive in the bloodstream or disseminate to distal tissues in Mus musculus (mice) or Peromyscus leucopus (white-footed mice) (Anderson et al., 1990; Barthold et al., 1991; Norris et al., 1995; Wang et al., 2002; Barbour et al., 2009; Baum et al., 2012; Chan et al., 2012) . Consistent with this observation, the ability of hematogenous dissemination by these spirochetes and the severity of manifestations vary among spirochete species and strains during infection in humans (Anderson et al., 1990; Wang et al., 2002; Carlsson et al., 2003; Logar et al., 2004; Dykhuizen et al., 2008; Wormser et al., 2008; Craig-Mylius et al., 2009) . These findings elucidate a spirochete strain-to-strain variation in the host-specific infectivity. Below, we discuss the potential mechanisms to drive the host tropisms of Lyme borreliae.
Hosts develop variable levels of innate and adaptive immune responses when infected with different species/strains of Lyme borreliae
The innate immune response is one factor that controls survival and disease severity of Lyme borreliae in vertebrate hosts (Barthold, 1999; Wang et al., 2001; Pachner et al., 2004; Steere and Glickstein, 2004) . Upon tick bite, spirochetes can be engulfed by dendritic cells at the bite site in the skin, which permits host cells to produce antigens and activate naive T cells (Mason et al., 2014) . Meanwhile, Lyme borreliae outer surface proteins recognized by multiple receptors (e.g. toll-like receptors) on the surface of macrophages lead to the activation of these cells (Talkington and Nickell, 2001; Alexopoulou et al., 2002; Wooten et al., 2002; Jacchieri et al., 2003; Soloski et al., 2014) . This activation promotes the production of proinflammatory cytokines and chemokines and the phagocytosis of spirochetes (Rittig et al., 1992; Modolell et al., 1994; Montgomery et al., 1996) . Effector molecules are then produced, which facilitates neutrophil infiltration of the infection site, resulting in disease manifestations in humans (Defosse and Johnson, 1992; Gebbia et al., 2001; Anguita et al., 2002) . Non-reservoir mammalian hosts (e.g. humans or M. musculus mouse models) in vivo, cultivated macrophages, or dendritic cells in vitro develop distinct levels of cytokines and chemokines in response to different Lyme borreliae species/strains (Strle et al., 2009; Mason et al., 2015) . The ability to trigger varying degrees of cytokine and chemokine production in different species/strains during infection is strongly correlated with the severity of resulting manifestations (Widhe et al., 2004; Jones et al., 2008; Strle et al., 2009; . Additionally, complement has been demonstrated to prevent spirochetes from efficiently disseminating to distal tissues and appears to play a role in the differential clearance of numerous Lyme borreliae species in vivo (Lawrenz et al., 2003; Woodman et al., 2007) . This is addressed in more detail in the following section.
The adaptive immune response also confers clearance of Lyme borreliae and may lead to clinical manifestations, such as arthritis. The B cell-mediated antibody Johnson et al. (2017) immune response plays a major role for pathogen clearance (Steere and Glickstein, 2004; Blum et al., 2018) . This B cell immunity is enhanced by B. burgdorferi-specific CD4 + T helper cell (T H 1) response, in which interferon-γ is the marker (Keane-Myers and Nickell, 1995; Kang et al., 1997; Zeidner et al., 1997) . In fact, humans infected with different Lyme borreliae strains generate distinct levels of interferon-γ (Strle et al., 2011) . When P. leucopus or M. musculus hosts were infected with different B. burgdorferi strains, the levels of antibodies against specific B. burgdorferi outer surface proteins and the spirochete burdens varied at heart and joint tissues (Wang et al., 2001; Baum et al., 2012) . These findings thus raise the possibility that the variation in antibody-mediated clearance induced by Lyme borreliae species/strains results in different levels of host competence. Further, invariant natural killer T cells (iNKT cells) recognize the lipids on the surface of B. burgdorferi to eradicate spirochetes, which limits their dissemination to joints and prevents Lyme disease-associated arthritis (Kinjo et al., 2006; Tupin et al., 2008; Lee et al., 2010; . However, whether this iNKT cell-mediated lipid binding activity, pathogen clearance and alleviation of manifestations is strain-specific remains unclear and warrant further investigations.
Lyme borreliae develop host-specific serum resistance activity to evade the complement Complement, composed of numerous serum proteins, is one of the innate immune responses in the vertebrate bloodstream (Figure 1 ) (Zipfel and Skerka, 2009; Ricklin et al., 2010) . The formation of enzymatic complement complex proteins, termed C3 convertases, is a critical control point in the complement cascade. Two distinct C3 convertases, C4b2a and C3bBb (named for the complement components that make them up) are formed from the activation of three pathways: the classical pathway, the mannose-binding lectin (MBL) pathway, and the alternative pathway (Ricklin et al., 2010; Merle et al., 2015) . C4b2a is generated by both the classical pathway, which is initiated by the binding of antibody, antigen, and complement C1qrs complexes, and the MBL pathway, initiated by microbial recognition via the formation of MBL-microbial carbohydrate complexes (Ricklin et al., 2010; Merle et al., 2015) . C3bBb is formed by the alternative pathway, which is initiated by binding of the complement component, C3b, to the microbial surface. C4b2a (consisting of C4b and C2a) and C3bBb (consisting of C3b and Factor Bb) then recruit other complement components to generate C5 convertases. This leads to downstream effects, including the release of proinflammatory peptides, the activation of phagocytic clearance and the formation of a membrane attack complex that can lyse pathogens (Ricklin et al., 2010; Merle et al., 2015) . Vertebrate hosts also produce complement regulators that bind to complement components (Zipfel and Skerka, 2009 ). These complement regulators include factor H (FH) as well as FH-like protein 1 (the truncated form of FH), both of which bind to C3b (Zipfel et al., 2002) . These complement regulators recognize and lead to the degradation of other complement proteins, eventually inhibiting the complement system (Meri, 2016). The complement components and their regulators exhibit sequence variation among vertebrate hosts (approximately 60% to 70% sequence identity among different classes of vertebrate animals) (Ripoche et al., 1988a; 1988b) . The sequence variation of these proteins suggests a host-to-host difference of complement. Consistent with the amino acid variation in different host complement proteins, different Lyme borreliae species/strains differ in their ability to survive in vertebrate host sera (Kurtenbach et al., 1998b; 2002a; Ullmann et al., 2003) (Fig. 2) . This difference in spirochete survival in the serum has been correlated with the spirochetes' capability to inactivate particular hosts' complement (Kurtenbach et al., 1998b; 2002a; Kuo et al., 2000; Nelson et al., 2000) .
Spirochetes produce polymorphic outer surface proteins that facilitate different levels of host complement evasion
A number of Lyme borreliae polymorphic proteins may be involved in host-to-host differences in complement evasion. The main candidates are five Lyme borreliae FH-binding proteins termed CRASPs (Complement Regulator Acquiring Surface Proteins), including CspA (also termed CRASP-1), CspZ (CRASP-2), ErpP (CRASP-3), ErpC (CRASP-4) and ErpA (CRASP-5) ( Table 2 ) (Kraiczy and Stevenson, 2013) . CspA is unique among the five CRASP proteins in that it is only expressed when the spirochetes are in the tick vector and at the biting site of host skin (Bykowski et al., 2007; Hart et al., 2018) . The lack of cspA expression results in the inability of spirochetes to survive in vertebrate host sera (Brooks et al., 2005; Kenedy et al., 2009; Hart et al., 2018) . Additionally, a cspA-deficient B. burgdorferi is cleared from nymphal ticks feeding on mice, eventually leading to a dearth of spirochetes transmitted from ticks to mice (Hart et al., 2018) . These defects in vitro and in vivo have been attributed to the lack of FH-binding activity of the cspA-deficient spirochetes to evade complement in a tick's blood meal (Hart et al., 2018) . Further, CspA is highly conserved within each Lyme borreliae species, but exhibits variation at the interspecific level (Wallich et al., 2005; Hammerschmidt et al., 2014) . These CspA variants differ in their ability to facilitate FH binding and serum survival in a host-specific manner and promote distinct levels of B. burgdorferi transmission from ticks to mice. This suggests CspA may play a role in promoting host-specific transmission of Lyme borreliae (Kraiczy et al., 2001; Wallich et al., 2005; Bhide et al., 2009; van Burgel et al., 2010; Hammerschmidt et al., 2014; Hart et al., 2018) . CspZ, when produced on the surface of a serum-sensitive spirochete, allows for binding to human FH and confers spirochete survival in human serum (Hartmann et al., 2006; Siegel et al., 2008) . Unlike cspA, cspZ is mainly expressed when spirochetes are in vertebrate hosts (Bykowski et al., 2007) . A cspZ-deficient B. burgdorferi strain has the ability to colonize mice at the same levels as its wild-type parental strain (Coleman et al., 2008) . However, Marcinkiewicz and colleagues (2019) incubated wild-type B. burgdorferi with human blood to induce the production of CspZ. They discovered that this wild-type spirochete displayed greater levels of bacteremia and dissemination in laboratory mice compared to a cspZ deletion mutant under the blood treatment condition (Marcinkiewicz et al., 2019) . These findings suggest that spirochetes do not require CspZ to survive in mammalian hosts, but its presence may enhance the infectivity of B. burgdorferi. Additionally, CspZ is not carried by all Lyme borreliae species/strains (Rogers and Marconi, 2007; Rogers et al., 2009) . Despite its high sequence conservation, i.e. 98% in B. burgdorferi strains, the ability of these strains to bind to human FH varies (Rogers and Marconi, 2007) . This finding implies that the 2% sequence difference may contribute to this variable human FH-binding activity and human complement evasion by B. burgdorferi (Brangulis et al., 2014) .
The CRASP genes erpP, erpC and erpA are encoded on highly homologous cp32-derived plasmids and are co-expressed when B. burgdorferi is in vertebrate hosts (Bykowski et al., 2007) . The proteins derived from these genes belong to the OspE-related protein family (OspE proteins) because of their sequence similarity (77-90% of sequence similarity) (Marconi et al., 1996; Stevenson et al., 1996; Akins et al., 1999; Kraiczy et al., 2004; Brissette et al., 2008) . These OspE proteins, though able to bind to human FH, do not promote human serum survival when they are individually produced on the surface of serum-sensitive borreliae (Siegel et al., 2010; Hammerschmidt et al., 2012) . However, simultaneously producing ErpP and ErpA in a serum-sensitive spirochete enables this strain to survive in human serum (Kenedy and Akins, 2011) . Transposon-inserted erpA mutant spirochetes co-infected with other transposon mutants exhibit decreased levels of colonization in C3H/ HeN mice (Lin et al., 2012) . These results suggest a nonessential but important function of OspE proteins in facilitating mammalian infection, consistent with the finding that not all Lyme borreliae species/strains encode these proteins (Alitalo et al., 2005) . Variation in OspE proteins has been observed among B. burgdorferi sl species/strains (Marconi et al., 1996; Stevenson et al., 1996; Akins et al., 1999; Metts et al., 2003; Alitalo et al., 2005; Hovis et al., 2006; Brissette et al., 2008) . OspE variants differ in their FH-binding ability in humans (Stevenson et al., 2002; McDowell et al., 2003; Alitalo et al., 2005) and other vertebrate hosts (Hellwage et al., 2001; Stevenson et al., 2002; McDowell et al., 2003; Alitalo et al., 2004; , implying a possibility that polymorphic OspE proteins may drive host-specific infection. Additional Lyme borreliae proteins including BBK32 and OspC have been recently identified to promote host complement inactivation and/or facilitate the spirochete bloodstream survival and dissemination (Caine and Coburn, 2015; Garcia et al., 2016; Caine et al., 2017) . BBK32, for example, binds to C1r to inhibit the initiation of the classical pathway, but high sequence identity of the variants among Lyme borreliae (greater than 70%) suggests that this protein is less likely to confer allelic variable and/or host-specific complement inactivation (Probert et al., 2001; Garcia et al., 2016) . OspC binds to C4b to prevent the formation of C4b2a, resulting in spirochete evasion of classical and MBL pathways (Table  2) (Caine et al., 2017) . In addition, an ospC-deficient B. burgdorferi exhibits the defects of bloodstream survival during early stages of murine infection, suggesting that OspC facilitates hematogenous dissemination (Caine and Coburn, 2015; Caine et al., 2017) . OspC has been known as one of the most polymorphic proteins produced in Lyme borreliae (approximately 60% sequence identity among B. burgdorferi sl) (Wilske et al., 1993) . This polymorphic protein also displays variable binding activity to human C4b (Caine et al., 2017) . These findings thus encourage further investigations into the potential role of OspC in promoting the adaptive divergence of B. burgdorferi sl host-specific infection at the species and strain level.
Polymorphic spirochete adhesins are potential contributors of host-Lyme borreliae association
In addition to the evasion of the host immune response, spirochete infectivity may also be driven by its ability to colonize host tissues (Coburn et al., 2005; . Such ability is partly attributed to the binding of Lyme borreliae to the extracellular matrix (ECM) components, including proteoglycans (Coburn et al., 2005; Brissette and Gaultney, 2014) . Glycosaminoglycans (GAGs), including dermatan sulfate and heparin sulfate, are the components of proteoglycan (Lin et al., 2017) . Borrelia burgdorferi colonizes mouse tissues less efficiently in mice deficient in decorin, a proteoglycan composed of GAGs (Brown et al., 2001 ). This observation is consistent with a positive correlation of the levels of GAG at mouse joints and the severity of arthritis during Lyme disease infection (Bramwell et al., 2014) . In fact, Lyme borreliae produce outer surface proteins (known as adhesins) that contribute to spirochete binding to GAGs and proteoglycans, resulting in cell adhesion and tissue colonization (Lin et al., 2017) . Decorin-binding protein A (DbpA) binds to proteoglycan components, including dermatan sulfate, decorin and biglycan (Guo et al., 1998; Parveen et al., 2003; Lin et al., 2014) (Table 2 ). Borrelia burgdorferi strains that lack dbpA (and its functional paralog dbpB) are unable to infect mice (Blevins et al., 2008; Shi et al., 2008; Weening et al., 2008) . This infectivity defect of the dbpBA-deficient mutant has been correlated with an inability of this strain to bind to decorin and dermatan sulfate (Benoit et al., 2011) . DbpA variants are extremely polymorphic among B. burgdorferi sl (58% sequence identity) (Roberts et al., 1998) and variants from different Lyme borreliae species/strains differ in their ability to bind to human decorin/dermatan sulfate/ biglycan (Benoit et al., 2011; Salo et al., 2011; Lin et al., 2014) . Further, the spirochetes producing each of these DbpA variants colonize mouse tissues at different levels (Lin et al., 2014) . Because the lengths of GAGs vary among different vertebrate hosts (Thunell et al., 1967; Barry et al., 1994) , these findings raise the possibility that DbpA may promote host-Lyme borreliae association by facilitating distinct levels of tissue colonization in different hosts. Additionally, Lyme borreliae produce OspF-related proteins (OspF proteins) that bind to heparan sulfate to promote spirochete attachment to mammalian cells (Antonara et al., 2007; Lin et al., 2015) (Table 2) . A recent study indicated that OspF variants from different B. burgdorferi strains display slightly different affinity in binding to porcine heparin sulfate (Lin et al., 2015) . This finding illuminates the potential role of OspF as a contributor to host-Lyme borreliae association. Overall, these variations in protein production among species/strains have allowed the spirochetes to effectively infect their specific classes of vertebrate hosts, thus reinforcing the host specialization and contributing to the divergence of Borrelia burgdorferi sl.
Barriers to investigate host-Lyme borreliae association: Application of appropriate spirochete strains and animal models
Investigating the host-specific roles of many Lyme borreliae proteins poses difficult challenges. Borrelia burgdorferi sl encodes nearly 100 outer surface proteins, many with redundant functions and/or expressed in a similar manner (Fraser et al., 1997; Dowdell et al., 2017) , which makes it difficult to delineate the phenotype promoted by each of these proteins and protein variants during infection. Thus, identifying the appropriate spirochete background strains with required defects, such as susceptibility to different hosts' sera, lack of infectivity in different hosts or lack of adhesion to different hosts' cells, is needed to study the influence of the protein variants on host competence. In addition, the major hurdle to studying the host-pathogen association of Lyme borreliae is that no well-established animal models for nonmammalian hosts are currently available. Though previous efforts using nonmammalian animals for Lyme borreliae infection have been documented (for birds, see Burgess, 1989; Bishop et al., 1994; Isogai et al., 1994; Olsen et al., 1996; Piesman et al., 1996; Richter et al., 2000; Kurtenbach et al., 2002b;  for reptiles see Lane, 1990; Lane and Quistad, 1998) , obtaining and maintaining wild-caught animals in the laboratory is often prohibitive. An additional challenge is that not all vertebrate hosts are able to persistently maintain Lyme borreliae (Burgess, 1989; Lane, 1990; Olsen et al., 1996; Piesman et al., 1996; Richter et al., 2000) . Furthermore, interspecies variation within animal orders such as rodents (Rodentia) and songbirds (Passeriformes) in Lyme borreliae competence have been observed (see Table 1 for references). These findings raise a general issue about which animal species appropriately represents a particular category of hosts. These difficulties warrant further investigations, as establishing nonmammalian Lyme borreliosis models would permit us to replicate the patterns of host competence seen in the field in a more controlled laboratory environment.
Conclusion and future work
Lyme borreliae are comprised of numerous strains and species that are maintained in an enzootic cycle by surviving in Ixodes ticks and various vertebrate hosts. Variation among spirochete species/strains in their ability to infect different hosts has been documented, but the cause of this variation remains unknown. Here, we discussed the possibility of variability of host immune response to different species of Lyme borreliae, resulting in variable infectivity. We also listed potential polymorphic Lyme borreliae proteins that could facilitate host-specific infection. Future work is needed to further define these mechanisms using different laboratory animals such as avian and mammalian hosts. This line of investigation will help design targeted intervention strategies against these mechanisms to block the infection route and ultimately reduce the burden of Lyme borreliosis. 
